Launch Readiness March 21, 2023 Perspectives on Pharma Market Access Launch Challenges & Strategy Part 2 9 Minute Read We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
Gross-to-Net March 6, 2023 5 Gross-to-Net Questions You Should Be Asking 4 Minute Read Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, managing Gross-To-Net can be complex.
